Literature DB >> 32702631

Recent progress in the study of Artemisiae Scopariae Herba (Yin Chen), a promising medicinal herb for liver diseases.

Yajie Cai1, Qi Zheng1, Rong Sun2, Jiarui Wu1, Xiaojiaoyang Li3, Runping Liu4.   

Abstract

Chronic liver diseases are global health problems representing a significant source of morbidity and mortality worldwide. Cholestasis is one of the most common clinical manifestations of almost all types of liver diseases regardless of etiologies and promotes the pathogenesis of liver. Artemisiae Scopariae Herba (ASH, or Yin Chen) is the most commonly used Traditional Chinese Medicine (TCM) herbal for the treatment of chronic liver diseases, especially cholestatic liver diseases. Various bioactive ingredients have been isolated and identified in ASH, however, most of them were not well characterized for their pharmacological effects. In the current review, we summarize clinical evidence demonstrating the promising therapeutic effects of ASH. We then introduce the profile of bioactive ingredients found in ASH and highlight the change of their abundance during different harvest times of ASH. We further thoroughly review recent advances in the studies of major bioactive ingredients in ASH, including scoparone, capillarisin, chlorogenic acid, and representative flavonoids, for their pharmacological effects, including choleretic, antioxidant, anti-inflammation, anti-fibrosis and other hepatoprotective activities. Underlying molecular targets and signaling networks are also outlined. In conclusion, ASH-based TCM prescriptions are promising strategies for the treatment of cholestatic liver diseases and are more effective than conventional therapies. The future advancement of pharmacology and toxicology researches of ASH and its bioactive ingredients will further contribute to the discovery of novel anti-cholestasis and hepatoprotective drugs.
Copyright © 2020 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Artemisiae Scopariae Herba; Capillarisin; Capillarisin (Pubchem CID: 5281342); Chlorogenic acid; Chlorogenic acid (Pubchem CID: 1794427); Hyperoside (Pubchem CID: 5281643); Rutin (Pubchem CID: 5280805); Scoparone; Scoparone (Pubchem CID: 8417); Yin Chen Hao decoction; Yin Zhi Huang

Mesh:

Substances:

Year:  2020        PMID: 32702631     DOI: 10.1016/j.biopha.2020.110513

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  6 in total

1.  6,7-Dimethoxycoumarin Influences the Erythroid Differentiation of Human Chronic Myelogenous Leukemia K562 Cells through Regulating FOXO3/p27 Signal Pathway.

Authors:  Li Zheng; Yu Wu; Fu Wang; Hui Shi; Bo Xu; Aihua Yang
Journal:  J Oncol       Date:  2022-05-14       Impact factor: 4.501

2.  Studies of Coumarin Derivatives for Constitutive Androstane Receptor (CAR) Activation.

Authors:  Shin-Hun Juang; Min-Tsang Hsieh; Pei-Ling Hsu; Ju-Ling Chen; Hui-Kang Liu; Fong-Pin Liang; Sheng-Chu Kuo; Chen-Yuan Chiu; Shing-Hwa Liu; Chen-Hsi Chou; Tian-Shung Wu; Hsin-Yi Hung
Journal:  Molecules       Date:  2020-12-31       Impact factor: 4.411

3.  Quality Evaluation of Artemisia capillaris Thunb. Based on Qualitative Analysis of the HPLC Fingerprint and UFLC-Q-TOF-MS/MS Combined with Quantitative Analysis of Multicomponents.

Authors:  Ying Dai; Zhihua Dou; Rongrong Zhou; Lin Luo; Li Bian; Yufeng Chen; Jinhua Tao; Zhixian Chen
Journal:  J Anal Methods Chem       Date:  2021-04-21       Impact factor: 2.193

4.  Stability of Chlorogenic Acid from Artemisiae Scopariae Herba Enhanced by Natural Deep Eutectic Solvents as Green and Biodegradable Extraction Media.

Authors:  Yingying Yue; Qingyang Li; Yan Fu; Jie Chang
Journal:  ACS Omega       Date:  2021-12-08

Review 5.  Artemisia scoparia and Metabolic Health: Untapped Potential of an Ancient Remedy for Modern Use.

Authors:  Anik Boudreau; Allison J Richard; Innocence Harvey; Jacqueline M Stephens
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-08       Impact factor: 5.555

6.  Network Pharmacology-Based Analysis on the Potential Biological Mechanisms of Yinzhihuang Oral Liquid in Treating Neonatal Hyperbilirubinemia.

Authors:  Tianqi Liang; Yanxiang Kong; Lijun Tang; Junbin Huang; Huabin Wang; Xiaoyi Fang; Airun Zhang; Chun Chen
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-05       Impact factor: 2.650

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.